Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Microarray techniques promised cancer biomarker discovery but yield poorly reproducible results.
• Critical analyses of gene expression methods in cancer research are infrequent.
• Ovarian cancer prognosis and treatment response require reliable molecular markers.

Purpose of the Study:

• To investigate global gene expression in ovarian cancer.
• To identify molecular biomarkers for chemoresistance and patient prognosis.
• To critically analyze the reproducibility and confounding factors in gene expression studies.

Main Methods:

• Global gene expression profiling of 97 ovarian cancer samples.
• Validation of findings using quantitative RT-PCR on 30 additional samples.
• Systematic analysis of gene expression against clinicopathological features.

Main Results:

• Histological tumor type was the primary driver of gene expression variability.
• Gene expression analyses for clinical endpoints (chemotherapy response, survival) lacked validation.
• CLASP1 showed association with disease-free survival in an independent cohort, warranting further investigation.

Conclusions:

• Histological homogeneity is crucial for reliable ovarian cancer gene expression studies.
• Poor reproducibility may stem from small, unequal sample classes and arbitrary data division.
• Clinical endpoints likely depend on complex, subtle molecular pathway changes difficult to detect.